Regenerative Medicine and the Feline Patient
Regenerative Medicine and the Feline Patient is a course designed to cover the basics about Stem Cell Therapy in veterinary medicine and
how it can be applied to feline medicine. The objectives of this course are to discuss the potential mechanisms of action, efficacy, and
safety. Guidelines on how to use stem cell therapy for the treatment of Arthritis, Chronic Renal Disease, IBD, and Gingivostomatitis as well as
case studies and outcome data will be presented.
SPEAKER
Robert Harman, DVM, MPVM
Dr. Harman founded and is the CEO of Vet-Stem, the first US-based commercial veterinary stem cell company. For 15 years prior to that, he was the CEO of
HTI-Bio-Services, a preclinical research company for veterinary and human pharmaceutical development. He has authored more than 500 contract study reports for
human and animal health companies throughout the world and for submission to the FDA and USDA in support of the development of new human and animal health
products. In his current position, he is the CEO and principal clinical development director of the programs at Vet-Stem to bring stem cell therapy to veterinary medicine.
He has been a frequent speaker at stem cell conferences in North America, Central America, Europe and the Middle East. He has authored peer-reviewed publications
and book chapters on stem cell therapy in veterinary medicine.
CE APPROVAL
This course has been certified by or provided by the following Certified Organization/s:
• AAVSB-Registry of Approved Continuing Education (RACE) - 1.00 Hours
• New York State Board of Veterinary Medical Examiners - 1.00 Hours
This webinar is sponsored by:
